

Session 1, Cape Town 5 - 8 February 2019
Session 2, Buenos Aires 9 - 12 April 2019
Session 3, Kiev 11 - 14 June 2019
Session 4, Amman 17 - 20 September 2019
Session 5, Pogdorica 22 - 25 October 2019
Session 6, Addis Ababa 10 - 13 December 2019
Session 7, New Delhi 18 - 21 February 2020
Session 8 - Costa Rica - VIRTUAL COURSE - 22 - 26 November 2021
Session 9 - Senegal - VIRTUAL COURSE - 28 March - 1 April 2021
Session 10 - Indonesia - VIRTUAL COURSE - 13 - 17 December 2021
NOTE: SESSIONS FACE-TO-FACE WILL BE ORGANISED CONSIDERING COVID-19 OUTBREAK IS CONTROLLED, AND VACCINATION IN EU COUNTRIES REACHES THE EXPECTED % OF COVERAGE IN EU POPULATION.
Antimicrobial Resistance (AMR) is a natural biological phenomenon which can be amplified by a wide range of factors. Over the past decades, inappropriate use of antimicrobials in human and veterinary medicine have accelerated the emergence and spread of resistant microorganisms. This situation is worsened by the lack of investment to develop new effective antibiotics or alternatives. The consequences are severe. In Europe it is estimated that around 25.000 patients die annually as a result of infections caused by antibiotic-resistant bacteria meaning an estimated cost of EUR 1.5 billion per annum. Combating antimicrobial resistance has become a global public health challenge.
AMR is a global public health concern and therefore a priority for the Commission which launched its second Action Plan against AMR based on a 'One-Health' approach, involving all sectors and aspects of AMR.
In its efforts at the international level, the Union particularly wants to focus on implementation of commitments made on AMR in international fora, including the WHO Global Action Plan on AMR as well as in the OIE and FAO resolutions. Sustaining political momentum, focusing on next steps and increasing international awareness and cooperation are also important components to follow-up.
The purpose of the training is to provide support on strategies and actions at promoting and strengthening the prudent use of antimicrobials and monitoring resistance, in veterinary, food safety and in public health sectors, reinforcing engagement and collaboration with international organisations, and intensifying cooperation with those most affected developing countries.
A key element of the training will be to work towards reinforcing engagement and collaboration with international organisations and intensify cooperation with countries outside of the European Union on AMR.
PARTNERS
JVL CONSULTING is a recognised Belgian company which provides consultancy services operating in the field of animal health and livestock production which has been implementing training activities within the initiative “Better Training for Safer Food” since 2009
JVL Consulting: http://www.jvl-c.com/en/page/btsf-better-training-for-safer-food.html
PROFILE PARTICIPANTS
The training programme is mainly addressed to officials from Competent Authorities involved, preferably at central level, in the developing, planning and coordinating control activities to tackle antimicrobial resistance in human medicine and veterinary medicine / food safety sectors.
The target audience is therefore
Decision, policy makers and senior officers from public health competent authorities
Decision, policy makers and senior officers from food safety competent authorities
Decision, policy makers and senior officers from competent authorities regarding the primary production of animals intended to be food.
Senior officers from national and/or regional networks related to AMR are also targeted to attend the course.
DATES FOR FUTURE SESSIONS
Session 01 – Cape town, South Africa – 2019-02-05/08
Session 02 – Buenos Aires, Argentina – 2019/04/09-12
Session 03 – Kiev, Ukraine – 2019-06-11/14
Session 04 – Amman, Jordan – 2019-09-17/20
Session 05 – Beijing, China – 2019-10-22/25
Session 06 – Addis Ababa, Ethiopia – 2019-12-10/13